United States DPP IV Inhibitor Market Research Report Forecast 2017-2021

June 2017 | 115 pages | ID: UD135B92893EN
S&P Consulting

Abstracts

The United States DPP IV Inhibitor Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the DPP IV Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This DPP IV Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)
company 8
company 9

United States DPP IV Inhibitor Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States DPP IV Inhibitor Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 DPP IV INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of DPP IV Inhibitor
1.2 DPP IV Inhibitor Market Segmentation by Type
  1.2.1 United States Production Market Share of DPP IV Inhibitor by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 DPP IV Inhibitor Market Segmentation by Application
  1.3.1 DPP IV Inhibitor Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of DPP IV Inhibitor (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON DPP IV INHIBITOR INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES DPP IV INHIBITOR MARKET COMPETITION BY MANUFACTURERS

3.1 United States DPP IV Inhibitor Production and Share by Manufacturers (2015 and 2016)
3.2 United States DPP IV Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States DPP IV Inhibitor Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers DPP IV Inhibitor Manufacturing Base Distribution, Production Area and Product Type
3.5 DPP IV Inhibitor Market Competitive Situation and Trends
  3.5.1 DPP IV Inhibitor Market Concentration Rate
  3.5.2 DPP IV Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES DPP IV INHIBITOR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States DPP IV Inhibitor Production and Market Share by Type (2012-2017)
4.2 United States DPP IV Inhibitor Revenue and Market Share by Type (2012-2017)
4.3 United States DPP IV Inhibitor Price by Type (2012-2017)
4.4 United States DPP IV Inhibitor Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES DPP IV INHIBITOR MARKET ANALYSIS BY APPLICATION

5.1 United States DPP IV Inhibitor Consumption and Market Share by Application (2012-2017)
5.2 United States DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES DPP IV INHIBITOR MANUFACTURERS ANALYSIS

6.1 AstraZeneca Plc. (UK)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Boehringer Ingelheim GmbH (Germany)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Eli Lilly and Company (US)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Merck & Co, Inc. (US)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Mitsubishi Tanabe Pharma Corporation (Japan)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Novartis AG (Switzerland)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Takeda Pharmaceutical Company Limited (Japan)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 DPP IV INHIBITOR MANUFACTURING COST ANALYSIS

7.1 DPP IV Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of DPP IV Inhibitor

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 DPP IV Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES DPP IV INHIBITOR MARKET FORECAST (2017-2021)

11.1 United States DPP IV Inhibitor Production, Revenue Forecast (2017-2021)
11.2 United States DPP IV Inhibitor Production, Consumption Forecast by Regions (2017-2021)
11.3 United States DPP IV Inhibitor Production Forecast by Type (2017-2021)
11.4 United States DPP IV Inhibitor Consumption Forecast by Application (2017-2021)
11.5 DPP IV Inhibitor Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of DPP IV Inhibitor
Table Classification of DPP IV Inhibitor
Figure United States Sales Market Share of DPP IV Inhibitor by Type in 2015
Table Application of DPP IV Inhibitor
Figure United States Sales Market Share of DPP IV Inhibitor by Application in 2015
Figure United States DPP IV Inhibitor Sales and Growth Rate (2011-2021)
Figure United States DPP IV Inhibitor Revenue and Growth Rate (2011-2021)
Table United States DPP IV Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table United States DPP IV Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 DPP IV Inhibitor Sales Share by Manufacturers
Figure 2016 DPP IV Inhibitor Sales Share by Manufacturers
Table United States DPP IV Inhibitor Revenue by Manufacturers (2015 and 2016)
Table United States DPP IV Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States DPP IV Inhibitor Revenue Share by Manufacturers
Table 2016 United States DPP IV Inhibitor Revenue Share by Manufacturers
Table United States Market DPP IV Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market DPP IV Inhibitor Average Price of Key Manufacturers in 2015
Figure DPP IV Inhibitor Market Share of Top 3 Manufacturers
Figure DPP IV Inhibitor Market Share of Top 5 Manufacturers
Table United States DPP IV Inhibitor Sales by Type (2012-2017)
Table United States DPP IV Inhibitor Sales Share by Type (2012-2017)
Figure United States DPP IV Inhibitor Sales Market Share by Type in 2015
Table United States DPP IV Inhibitor Revenue and Market Share by Type (2012-2017)
Table United States DPP IV Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of DPP IV Inhibitor by Type (2012-2017)
Table United States DPP IV Inhibitor Price by Type (2012-2017)
Figure United States DPP IV Inhibitor Sales Growth Rate by Type (2012-2017)
Table United States DPP IV Inhibitor Sales by Application (2012-2017)
Table United States DPP IV Inhibitor Sales Market Share by Application (2012-2017)
Figure United States DPP IV Inhibitor Sales Market Share by Application in 2015
Table United States DPP IV Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States DPP IV Inhibitor Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Market Share (2012-2017)
Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company (US) DPP IV Inhibitor Market Share (2012-2017)
Table Merck & Co, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck & Co, Inc. (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co, Inc. (US) DPP IV Inhibitor Market Share (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) DPP IV Inhibitor Market Share (2012-2017)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 DPP IV Inhibitor Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 DPP IV Inhibitor Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DPP IV Inhibitor
Figure Manufacturing Process Analysis of DPP IV Inhibitor
Figure DPP IV Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
Table Major Buyers of DPP IV Inhibitor
Table Distributors/Traders List
Figure United States DPP IV Inhibitor Production and Growth Rate Forecast (2017-2021)
Figure United States DPP IV Inhibitor Revenue and Growth Rate Forecast (2017-2021)
Table United States DPP IV Inhibitor Production Forecast by Type (2017-2021)
Table United States DPP IV Inhibitor Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)